Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease

NCT00104442 is registered in ClinicalTrials.gov with Novartis as lead sponsor.

NCT NCT00104442
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00104442 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease
Lead sponsor
Novartis
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2003
Completion date
April 30, 2006
Enrollment
80
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease